{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:39:24Z","timestamp":1772707164339,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.critrevonc.2011.10.001","type":"journal-article","created":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T00:34:47Z","timestamp":1320280487000},"page":"283-292","source":"Crossref","is-referenced-by-count":52,"title":["Hepatosplenic gamma-delta T-cell lymphoma"],"prefix":"10.1016","volume":"83","author":[{"given":"Andr\u00e9s J.M.","family":"Ferreri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Govi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano A.","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2011.10.001_bib0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.immuni.2006.05.010","article-title":"Stage-specific and differential notch dependency at the alphabeta and gammadelta T lineage bifurcation","volume":"25","author":"Ciofani","year":"2006","journal-title":"Immunity"},{"issue":"1 Feb","key":"10.1016\/j.critrevonc.2011.10.001_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1525-1578(10)60610-1","article-title":"Hepatosplenic and subcutaneous panniculitis-like gamma\/delta T cell lymphomas are derived from different Vdelta subsets of gamma\/delta T lymphocytes","volume":"2","author":"Przybylski","year":"2000","journal-title":"J Mol Diagn"},{"issue":"June (6)","key":"10.1016\/j.critrevonc.2011.10.001_bib0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/jcp.43.6.461","article-title":"Preferential localisation of human lymphocytes bearing gamma delta T cell receptors to the red pulp of the spleen","volume":"43","author":"Bordessoule","year":"1990","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0020","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","article-title":"Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0025","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/ajcp\/102.3.310","article-title":"Gamma\/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen","volume":"102","author":"Ross","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0030","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1182\/blood.V89.9.3490","article-title":"Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in gammadelta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders","volume":"89","author":"Salhany","year":"1997","journal-title":"Blood"},{"issue":"July (7)","key":"10.1016\/j.critrevonc.2011.10.001_bib0035","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/lt.21748","article-title":"Hepatosplenic gammadelta T-cell lymphoma after liver transplantation: report of the first 2 cases and review of the literature","volume":"15","author":"Roelandt","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0040","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"issue":"September (3 Pt 1)","key":"10.1016\/j.critrevonc.2011.10.001_bib0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/clin.1996.0122","article-title":"Cytotoxic gamma delta I lymphocytes associated with an Epstein-Barr virus-induced posttransplantation lymphoproliferative disorder","volume":"80","author":"Rothenberg","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0050","first-page":"215","article-title":"Hepatosplenic gamma delta T-cell lymphoma associated with hepatitis B virus infection","volume":"44","author":"Ozaki","year":"1998","journal-title":"J Med Invest"},{"issue":"February (2)","key":"10.1016\/j.critrevonc.2011.10.001_bib0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","article-title":"Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease","volume":"44","author":"Mackey","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0060","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1136\/gut.2008.163279","article-title":"Hepatosplenic T cell lymphoma in inflammatory bowel disease","volume":"57","author":"Shale","year":"2008","journal-title":"Gut"},{"issue":"August (8)","key":"10.1016\/j.critrevonc.2011.10.001_bib0065","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cgh.2009.01.004","article-title":"Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis","volume":"7","author":"Siegel","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"August (8)","key":"10.1016\/j.critrevonc.2011.10.001_bib0070","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0075","unstructured":"Kotlyar DS, Osterman MT, Diamond RH. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol [Epub 2010 Oct 1]."},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0080","series-title":"WHO classification of tumours of hematopoietic and lymphoid tissues","first-page":"292","article-title":"Hepatosplenic T-cell lymphoma","author":"Gaulard","year":"2008"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0085","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","article-title":"Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta","volume":"75","author":"Farcet","year":"1990","journal-title":"Blood"},{"issue":"September (3)","key":"10.1016\/j.critrevonc.2011.10.001_bib0090","first-page":"617","article-title":"Expression of the alpha\/beta and gamma\/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma\/delta T-cell lymphomas","volume":"137","author":"Gaulard","year":"1990","journal-title":"Am J Pathol"},{"issue":"April (4)","key":"10.1016\/j.critrevonc.2011.10.001_bib0095","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1365-2559.2000.00893.x","article-title":"gammadelta T-cell lymphomas: a homogeneous entity?","volume":"36","author":"de Wolf-Peeters","year":"2000","journal-title":"Histopathology"},{"issue":"July (7)","key":"10.1016\/j.critrevonc.2011.10.001_bib0100","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00000478-200107000-00004","article-title":"Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution","volume":"25","author":"Allory","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"July (3)","key":"10.1016\/j.critrevonc.2011.10.001_bib0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0037-1963(03)00137-9","article-title":"Gammadelta T-cell lymphomas","volume":"40","author":"Gaulard","year":"2003","journal-title":"Semin Hematol"},{"issue":"June (6)","key":"10.1016\/j.critrevonc.2011.10.001_bib0110","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","article-title":"Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment","volume":"20","author":"Falchook","year":"2009","journal-title":"Ann Oncol"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2011.10.001_bib0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10428190500272556","article-title":"Immunophenotypic profile and role of adhesion molecules in splenic marginal zone lymphoma with bone marrow involvement","volume":"47","author":"Florena","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2011.10.001_bib0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0046-8177(94)90179-1","article-title":"Hepatosplenic T-cell lymphoma: an unusual case of a gamma delta T-cell lymphoma with a blast-like terminal transformation","volume":"25","author":"Mastovich","year":"1994","journal-title":"Hum Pathol"},{"issue":"July (5)","key":"10.1016\/j.critrevonc.2011.10.001_bib0125","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4161\/auto.5920","article-title":"Apoptosis inhibition by Bcl-2 gives way to autophagy in glucocorticoid-treated lymphocytes","volume":"4","author":"Swerdlow","year":"2008","journal-title":"Autophagy"},{"issue":"June (6)","key":"10.1016\/j.critrevonc.2011.10.001_bib0130","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"issue":"September (3)","key":"10.1016\/j.critrevonc.2011.10.001_bib0135","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1309\/BM40-YM6J-9T3X-MH8H","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features","volume":"116","author":"Vega","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"July (7)","key":"10.1016\/j.critrevonc.2011.10.001_bib0140","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/00000478-200007000-00016","article-title":"Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma","volume":"24","author":"Suarez","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"March (3)","key":"10.1016\/j.critrevonc.2011.10.001_bib0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/gcc.2870120302","article-title":"Consistent presence of isochromosome 7q in hepatosplenic T gamma\/delta lymphoma: a new cytogenetic-clinicopathologic entity","volume":"12","author":"Wang","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"issue":"March (3)","key":"10.1016\/j.critrevonc.2011.10.001_bib0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/gcc.10021","article-title":"Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression","volume":"33","author":"Wlodarska","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0160","first-page":"1453","article-title":"Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma\/delta lymphoma","volume":"10","author":"Jonveaux","year":"1996","journal-title":"Leukemia"},{"issue":"October (4)","key":"10.1016\/j.critrevonc.2011.10.001_bib0165","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00428-006-0267-5","article-title":"Hepatosplenic gammadelta T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration","volume":"449","author":"Tamaska","year":"2006","journal-title":"Virchows Arch"},{"issue":"December (7)","key":"10.1016\/j.critrevonc.2011.10.001_bib0170","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S1053-0770(97)90118-X","article-title":"In vitro interference of the red cell substitute pyridoxalated hemoglobin\u2013polyoxyethylene with blood compatibility, coagulation, and clinical chemistry testing","volume":"11","author":"Alonsozana","year":"1997","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"January (5)","key":"10.1016\/j.critrevonc.2011.10.001_bib0175","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2008-07-166363","article-title":"Gene expression profiling of peripheral T-cell lymphoma including gammadelta T-cell lymphoma","volume":"113","author":"Miyazaki","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002770050272","article-title":"Gamma\/delta T-cell hepatosplenic lymphoma: review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia","volume":"74","author":"Sallah","year":"1997","journal-title":"Ann Hematol"},{"issue":"March (9)","key":"10.1016\/j.critrevonc.2011.10.001_bib0185","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2010-09-271437","article-title":"How I diagnose and treat splenic lymphomas","volume":"117","author":"Iannitto","year":"2011","journal-title":"Blood"},{"issue":"June (6)","key":"10.1016\/j.critrevonc.2011.10.001_bib0190","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","article-title":"Hepatosplenic and other gammadelta T-cell lymphomas","volume":"127","author":"Vega","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1096-8652(199901)60:1<61::AID-AJH10>3.0.CO;2-L","article-title":"Hepato-splenic gammadelta T-cell lymphoma: a rare entity mimicking the hemophagocytic syndrome","volume":"60","author":"Nosari","year":"1999","journal-title":"Am J Hematol"},{"issue":"June (6)","key":"10.1016\/j.critrevonc.2011.10.001_bib0200","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1023\/A:1008349422735","article-title":"T-cell prolymphocytic leukaemia: does the expression of CD8+ phenotype justify the identification of a new subtype? Description of two cases and review of the literature","volume":"10","author":"Ascani","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0205","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0046-8177(94)90179-1","article-title":"Hepatosplenic T-cell lymphoma: an unusual case of a gamma delta T-cell lymphoma with a blast-like terminal transformation","volume":"25","author":"Mastovich","year":"1994","journal-title":"Hum Pathol"},{"issue":"April (7)","key":"10.1016\/j.critrevonc.2011.10.001_bib0215","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"issue":"October (10)","key":"10.1016\/j.critrevonc.2011.10.001_bib0220","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","article-title":"Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification","volume":"15","author":"Savage","year":"2004","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.critrevonc.2011.10.001_bib0225","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1245\/s10434-009-0470-0","article-title":"Importance of early splenectomy in patients with hepatosplenic T-cell lymphoma and severe thrombocytopenia","volume":"16","author":"Gumbs","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"December (12)","key":"10.1016\/j.critrevonc.2011.10.001_bib0230","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00277-008-0523-7","article-title":"Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation","volume":"87","author":"Otrock","year":"2008","journal-title":"Ann Hematol"},{"issue":"December (2)","key":"10.1016\/j.critrevonc.2011.10.001_bib0235","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5507\/bp.2005.040","article-title":"T-cell gamma\/delta hepatosplenic lymphoma\u2014prolonged remission induced by aggressive first line treatment","volume":"149","author":"Proch\u00e1zka","year":"2005","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0240","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1365-2141.2002.03537_3.x","article-title":"Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin","volume":"117","author":"Iannitto","year":"2002","journal-title":"Br J Haematol"},{"issue":"December (6)","key":"10.1016\/j.critrevonc.2011.10.001_bib0245","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/pbc.22129","article-title":"Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant","volume":"53","author":"Schafer","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"October (10)","key":"10.1016\/j.critrevonc.2011.10.001_bib0250","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1080\/10428190701584007","article-title":"Clinical outcome of incidental pelvic node malignant B-cell lymphomas discovered at the time of radical prostatectomy","volume":"48","author":"He","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"March (3)","key":"10.1016\/j.critrevonc.2011.10.001_bib0255","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/10428190601126941","article-title":"Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma","volume":"48","author":"Konuma","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"October (10)","key":"10.1016\/j.critrevonc.2011.10.001_bib0260","first-page":"E25","article-title":"Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma","volume":"86","author":"Ooi","year":"2001","journal-title":"Haematologica"},{"issue":"September (9)","key":"10.1016\/j.critrevonc.2011.10.001_bib0265","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ajh.21774","article-title":"T cell lymphoma responsive to 2\u2032-deoxycoformycin therapy","volume":"85","author":"Bennett","year":"2010","journal-title":"Am J Hematol"},{"issue":"November (11)","key":"10.1016\/j.critrevonc.2011.10.001_bib0270","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/01.mph.0000187431.37369.f5","article-title":"Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature","volume":"27","author":"Domm","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"issue":"February (2)","key":"10.1016\/j.critrevonc.2011.10.001_bib0275","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajh.10466","article-title":"Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation","volume":"75","author":"Gassas","year":"2004","journal-title":"Am J Hematol"},{"issue":"August (2)","key":"10.1016\/j.critrevonc.2011.10.001_bib0280","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1532\/IJH97.04149","article-title":"Hepatosplenic alphabeta T-cell lymphoma with myelodysplastic syndrome","volume":"82","author":"Takaku","year":"2005","journal-title":"Int J Hematol"},{"issue":"June (6)","key":"10.1016\/j.critrevonc.2011.10.001_bib0285","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-0609.2006.00646.x","article-title":"A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab","volume":"76","author":"Mittal","year":"2006","journal-title":"Eur J Haematol"},{"issue":"March (5)","key":"10.1016\/j.critrevonc.2011.10.001_bib0290","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bmt.1705272","article-title":"Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation","volume":"37","author":"Sakai","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.critrevonc.2011.10.001_bib0295","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbmt.2008.04.004","article-title":"Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience","volume":"14","author":"Chen","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"May (14)","key":"10.1016\/j.critrevonc.2011.10.001_bib0300","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1200\/JCO.2007.14.1366","article-title":"Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Soci\u00e9t\u00e9 Francaise de Greffe de Mo\u00eblle et de Th\u00e9rapie Cellulaire","volume":"26","author":"Le Gouill","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0305","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2141.2000.02129.x","article-title":"In vitro and in vivo effects of 2\u2032-deoxycoformycin (pentostatin) on tumour cells from human gammadelta+T-cell malignancies","volume":"110","author":"Aldinucci","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2011.10.001_bib0310","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/10428190109099342","article-title":"2\u2032-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma","volume":"42","author":"Grigg","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"March (3)","key":"10.1016\/j.critrevonc.2011.10.001_bib0315","first-page":"ECR14","article-title":"Pentostatin (2\u2032-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas","volume":"90","author":"Corazzelli","year":"2005","journal-title":"Haematologica"},{"issue":"July (7)","key":"10.1016\/j.critrevonc.2011.10.001_bib0320","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1080\/10428190802087488","article-title":"Long-term survival in two patients with hepatosplenic T cell lymphoma treated with interferon-alpha","volume":"49","author":"Humphreys","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"April (4)","key":"10.1016\/j.critrevonc.2011.10.001_bib0325","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ajh.21062","article-title":"Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen","volume":"83","author":"Tey","year":"2008","journal-title":"Am J Hematol"},{"issue":"September (9)","key":"10.1016\/j.critrevonc.2011.10.001_bib0330","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1600-6143.2004.00521.x","article-title":"Post transplant T-cell lymphoma: a case series of four patients from a single unit and review of the literature","volume":"4","author":"Rajakariar","year":"2004","journal-title":"Am J Transplant"},{"issue":"May (5)","key":"10.1016\/j.critrevonc.2011.10.001_bib0335","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/annonc\/mdn119","article-title":"Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine","volume":"19","author":"Jaeger","year":"2008","journal-title":"Ann Oncol"},{"issue":"November (11)","key":"10.1016\/j.critrevonc.2011.10.001_bib0340","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/eji.200939432","article-title":"Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD","volume":"39","author":"Koenecke","year":"2009","journal-title":"Eur J Immunol"},{"issue":"June (12)","key":"10.1016\/j.critrevonc.2011.10.001_bib0345","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2005-09-3581","article-title":"Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere","volume":"107","author":"Bonder","year":"2006","journal-title":"Blood"},{"issue":"March (3)","key":"10.1016\/j.critrevonc.2011.10.001_bib0350","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/eji.200838812","article-title":"A regulatory cross-talk between Vgamma9Vdelta2T lymphocytes and mesenchymal stem cells","volume":"39","author":"Martinet","year":"2009","journal-title":"Eur J Immunol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842811002320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842811002320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:13:03Z","timestamp":1593216783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842811002320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1040842811002320"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2011.10.001","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}